Who owns TRAVERE THERAPEUTICS INC (TVTX?
- CUSIP Number: 89422gaa5
Tip: Access positions for across all investors
Analyze quarterly positions in Travere Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Travere Therapeutics stock
Who bought or sold TRAVERE THERAPEUTICS INC (TVTX this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Wolverine Asset Management | 45M | $29M | 0% | Mar 2024 |
|
| D. E. Shaw & Co | 41M | $26M | 0% | Mar 2024 |
|
| Highbridge Capital Management | 31M | $20B | 5% | Mar 2024 |
|
| UBS O'Connor | 26M | $16M | 100% | Mar 2024 |
|
| Lazard Asset Management | 25M | $17M | 4% | Dec 2023 |
|
| Citigroup | 20M | $13M | 0% | Mar 2024 |
|
| Aviva | 20M | $13M | 0% | Mar 2024 |
|
| Capstone Investment Advisors | 17M | $11M | -10% | Mar 2024 |
|
| Silverback Asset Management | 17M | $11M | 32% | Mar 2024 |
|
| CNH Partners | 7.7M | $4.9M | 100% | Mar 2024 |
|
| Jane Street | 3.3M | $2.1M | -8% | Mar 2024 |
|
| BlackRock | 3.2M | $2.0M | 45% | Mar 2024 |
|
| Readystate Asset Management | 3.0M | $1.9M | 0% | Mar 2024 |
|
| Morgan Stanley | 2.6M | $1.6M | -16% | Mar 2024 |
|
| Point72 Asset Management | 2.6M | $1.6M | 0% | Mar 2024 |
|
| Lion Point Capital | 1.0M | $630k | 0% | Mar 2024 |
|
| Nomura Holdings | 564k | $4.4M | 17% | Mar 2024 |
|
| Context Capital Management | 61k | $39M | -100% | Mar 2024 |
|
Who sold out of Travere Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Braidwell | Dec 2023 | 17M | $11M |
| Segantii Capital Management | Dec 2023 | 10M | $6.7M |
| Linden Advisors | Sep 2023 | 1.5M | $963M |
| Jpmorgan Chase & Co | Dec 2023 | 125k | $81k |